Cytokinetics, Incorporated Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (31)

Latest Posts

About This Stock More About This Stock
Cytokinetics Announces Pricing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Thursday, July 16, 2020 7:15 PM EDT
Cytokinetics, Incorporated today announced the pricing of an underwritten public offering of 7,291,667 shares of its common stock at a price to the public of $24.00 per share, before underwriting discounts and commissions.
In this article: CYTK
Read
5 Tiny Biotech Stocks With Superb Growth Potential
Article By: Swarup Gupta
Wednesday, February 13, 2019 11:40 AM EDT
After a disastrous end to 2018, pharma stocks have started the New Year on a considerably strong note. Here are several biotech stocks which would be a smart choice to invest in.
In this article: BDSI, CYTK, CLDX, ADRO, AEZS Also: XBI, BMY, CELG, LLY, LOXO
Read
3 Biotechs With Upcoming Data To Be Presented At Conferences
Article By: Scott Matusow
Tuesday, June 12, 2018 5:24 AM EDT
Biotech stocks tend to have strong movement when their respective companies have binary events upcoming in short order. Here are 3 companies with upcoming data to be presented at data conferences this week.
In this article: CYTK, ARQL, AFMD Also: MYOK, AZN
Read
Update On Currently Recommended Stocks
Article By: SmithOnStocks
Monday, September 25, 2017 4:19 PM EDT
In this report I update my objectives and include several buy recommendations in the biotech sphere.
In this article: CYTK, AIS, NWBO, PTLA, RGEN, CYRX, BMY, ALIM, AGEN, EYPT, AMAG, WINT, AMGN, GNE, BIIB
Read
Cytokinetics: Reiteration Of My Long Standing Buy Recommendation Based On An Extraordinary Pipeline
Article By: SmithOnStocks
Monday, August 7, 2017 5:01 PM EDT
CYTK reported a loss of $29 million in the second quarter and currently has a $332 million cash position which management indicates can carry the Company through 2H, 2019.
In this article: CYTK
Read

PARTNER HEADLINES

Latest Tweets for $CYTK

No tweets yet!

$CYTK

Is Gilead Sciences About To Buy Vertex For $45 Billion?
Susan Miller 5/7/2015 8:08:33 PM

What's your take on $CYTK?

Small Cap Best & Worst Report - October 9, 2014
Wall St. Wolf 10/13/2014 2:04:38 AM

Yes, $CYTK is a pos. If it gets over 4 again, I'm out.

1 to 2 of 2 comments